RLAY
Relay Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$19.39-2.64%
Price as of Jul 20, 2026
RLAY ownership
Relay Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$5.4M
Insider trades by month Buys Sells
Jan
Mar
Apr
May
Jun
Jul
Context3-month price +21.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | Patel Sanjivdirector, officer: President and CEO | Grant | 3,056 | $6.95 |
| Jul 8, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 8,660 | $18.71 |
| Jul 8, 2026 | Patel Sanjivdirector, officer: President and CEO | Sell | 48,199 | $19.58 |
| Jul 8, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $18.69 |
| Jul 2, 2026 | Rahmer Peterofficer: See remarks | Sell | 50,000 | $19.09 |
| Jul 2, 2026 | Rahmer Peterofficer: See remarks | Grant | 3,056 | $6.95 |
| Jun 24, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 93,456 | $16.94 |
| Jun 24, 2026 | Bergstrom Donald Aofficer: President, R&D | Option | 93,456 | $4.12 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 51,560 | $4.45 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 61,563 | $5.22 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 51,560 | $16.97 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 56,323 | $5.04 |
| Jun 24, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $17.01 |
| Jun 10, 2026 | Borisy Alexisdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Murcko Markdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | HILL LINDA Adirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Dable Habib Jdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | Mazumdar Clairedirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | COATS LONNELdirector | Grant | 32,947 | $14.09 |
| Jun 10, 2026 | INGRAM DOUGLAS Sdirector | Grant | 32,947 | $14.09 |
| May 14, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $12.86 |
| Apr 30, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 972 | $14.79 |
| Apr 30, 2026 | Rahmer Peterofficer: See remarks | Sell | 753 | $14.79 |
| Apr 30, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 1,490 | $14.79 |
| Apr 9, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $13.01 |
| Apr 9, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Option | 1,800 | $5.22 |
| Apr 9, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 1,800 | $15.00 |
| Mar 11, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 17,717 | $10.06 |
| Jan 29, 2026 | Catinazzo Thomasofficer: Chief Financial Officer | Sell | 13,820 | $7.62 |
| Jan 29, 2026 | Bergstrom Donald Aofficer: President, R&D | Sell | 18,895 | $7.62 |
Source: RLAY SEC Form 4 filings, latest Jul 8, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RLAY positions over the last 6 months (SEC Form 13F).
Increased
170
New positions
94
Reduced
116
Sold out
59
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27.9M | May 18, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Unchanged | 27.9M | Feb 18, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 17.0M | Feb 17, 2026 |
| COMMODORE CAPITAL LP | Unchanged | 17.0M | May 15, 2026 |
| CASDIN CAPITAL, LLC | Increased | 14.4M | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 13.9M | Feb 17, 2026 |
| BLACKROCK, INC. | Reduced | 13.2M | Feb 12, 2026 |
| CASDIN CAPITAL, LLC | Increased | 13.0M | Feb 17, 2026 |
| BLACKROCK, INC. | Reduced | 13.0M | May 13, 2026 |
| PERCEPTIVE ADVISORS LLC | Increased | 9.8M | May 29, 2026 |
| VANGUARD GROUP INC | Increased | 9.7M | Jan 29, 2026 |
| BELLEVUE GROUP AG | Reduced | 8.3M | Feb 17, 2026 |
| BELLEVUE GROUP AG | Reduced | 7.8M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7.4M | May 15, 2026 |
| STATE STREET CORP | Increased | 6.4M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.